XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 91 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $625,000 | +97.2% | 127,094 | +6.7% | 0.00% | 0.0% |
| Q2 2020 | $317,000 | -8.9% | 119,071 | -33.3% | 0.00% | -33.3% |
| Q1 2020 | $348,000 | +96.6% | 178,650 | +610.3% | 0.00% | +200.0% |
| Q4 2019 | $177,000 | -76.5% | 25,152 | -66.5% | 0.00% | -50.0% |
| Q1 2019 | $753,000 | – | 75,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|